Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Ari Zoldan

  • Analysis & Opinion

Ari Zoldan's Opinion & Analysis
A complete archive of Ari Zoldan's articles, including current analysis & opinion.

It is common knowledge that moving forward, electric vehicles (EVs) will dominate the transportation industry. No matter if the vehicle is passenger driven or self-driven, a passenger vehicle or a...
It is common knowledge that moving forward, electric vehicles (EVs) will dominate the transportation industry. No matter if the vehicle is passenger driven or self-driven, a passenger vehicle or a...
Protalix Biotherapeutics (NYSE:PLX) is a drug discovery company that develops therapies for orphan diseases. Protalix has been leveraging its proprietary ProCellEx® platform, which is the key to...
A trend has the investment community buzzing with excitement, with talk about it reimagining how investors evaluate positions: ESG—Environmental, Social, and Corporate Governance. But what is...
A trend has the investment community buzzing with excitement, with talk about it reimagining how investors evaluate positions: ESG. But what is ESG? Is it a marketing gimmick? Or a fundamentally based...
Besides cryptocurrency, another asset class that is gaining prominence and quickly becoming a part of many people’s lexicons is NFTs. From art and music to GIFs and tweets, the so-called digital...
Creating A New Standard For Treating CNS DiseaseInhibikase Therapeutics (NASDAQ:IKT) is a biotechnology company focused on creating new therapies for Central Nervous System (CNS) based diseases. The...